Short Interest in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Expands By 308.4%

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report) was the target of a significant increase in short interest in the month of May. As of May 29th, there was short interest totaling 5,546 shares, an increase of 308.4% from the May 14th total of 1,358 shares. Approximately 3.7% of the shares of the company are sold short. Based on an average daily volume of 1,205 shares, the short-interest ratio is presently 4.6 days.

iShares Neuroscience and Healthcare ETF Stock Up 0.4%

IBRN stock traded up $0.13 on Friday, reaching $34.83. 1,300 shares of the company’s stock were exchanged, compared to its average volume of 1,837. The stock has a fifty day moving average of $34.67 and a 200-day moving average of $32.95. iShares Neuroscience and Healthcare ETF has a twelve month low of $21.78 and a twelve month high of $37.00. The firm has a market cap of $5.22 million, a PE ratio of 15.61 and a beta of 0.77.

Get iShares Neuroscience and Healthcare ETF alerts:

iShares Neuroscience and Healthcare ETF Company Profile

(Get Free Report)

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.

See Also

• Five stocks we like better than iShares Neuroscience and Healthcare ETF
• Time to Sell? 3 Winners With Fading Technical Momentum
• Why These 2 Hotel Stocks Are Beating Travel Peers
• This Energy Stock Has Quietly Soared 130% in a Year
• 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups

Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.